The medicines suppress progression of aneurysms in mouse models and people with Marfan syndrome, potentially reducing the risk of vascular tears, early death or the need for surgery. "The new ...
The standard treatment for the connective tissue disorder Marfan's syndrome (MFS) is β-blockade, aimed at reducing aortic wall stress. Angiotensin II type 1 and 2 receptors (AT 1 and AT 2 ...